DE3462895D1 - (1h-tetrazol-5-yl)-2(1h)-quinolinones - Google Patents

(1h-tetrazol-5-yl)-2(1h)-quinolinones

Info

Publication number
DE3462895D1
DE3462895D1 DE8484103231T DE3462895T DE3462895D1 DE 3462895 D1 DE3462895 D1 DE 3462895D1 DE 8484103231 T DE8484103231 T DE 8484103231T DE 3462895 T DE3462895 T DE 3462895T DE 3462895 D1 DE3462895 D1 DE 3462895D1
Authority
DE
Germany
Prior art keywords
tetrazol
quinolinones
quinolinone
cyano
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8484103231T
Other languages
English (en)
Inventor
Terry L Wright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of DE3462895D1 publication Critical patent/DE3462895D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
DE8484103231T 1983-03-25 1984-03-23 (1h-tetrazol-5-yl)-2(1h)-quinolinones Expired DE3462895D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/478,965 US4735948A (en) 1983-03-25 1983-03-25 (1H-tetrazol-5-yl)-2(1H)-quinolinones and-naphthyridones and antiallergic use thereof

Publications (1)

Publication Number Publication Date
DE3462895D1 true DE3462895D1 (de) 1987-05-07

Family

ID=23902120

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484103231T Expired DE3462895D1 (de) 1983-03-25 1984-03-23 (1h-tetrazol-5-yl)-2(1h)-quinolinones

Country Status (17)

Country Link
US (1) US4735948A (de)
EP (1) EP0120483B1 (de)
JP (1) JPS59176276A (de)
KR (1) KR900003650B1 (de)
AT (1) ATE26276T1 (de)
AU (1) AU562115B2 (de)
CA (1) CA1241001A (de)
DE (1) DE3462895D1 (de)
DK (1) DK163238C (de)
ES (1) ES8601963A1 (de)
GR (1) GR81908B (de)
IE (1) IE57073B1 (de)
IL (1) IL71319A (de)
NO (1) NO841157L (de)
NZ (1) NZ207581A (de)
PT (1) PT78289B (de)
ZA (1) ZA842065B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT79031B (en) * 1983-08-20 1986-08-22 Boots Co Plc Therapeutic agents
US5358949A (en) * 1986-03-05 1994-10-25 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives and salts thereof and anti-arrhythmic agents containing the carbostyril derivatives
US5037826A (en) * 1986-10-15 1991-08-06 Schering Corporation 1-substituted naphthyridine and pyridopyrazine derivatives
EP0267691A3 (de) * 1986-10-15 1989-08-23 Schering Corporation Verwendung von 1-substituierten Naphthyridin- und Pyridopyrazinderivaten für die Herstellung von Immunosuppressoren-arzneimittel.
US4916131A (en) * 1986-10-15 1990-04-10 Schering Corporation Naphthyridine derivatives and method for treating allergic reactions
US5064837A (en) * 1989-11-13 1991-11-12 Schering Corporation 3-substituted-1-aryl-2(h)-quinolones and their pharmaceutical compositions
GB9026389D0 (en) * 1990-12-05 1991-01-23 Merck Sharp & Dohme Therapeutic agents
GB9125485D0 (en) * 1991-11-29 1992-01-29 Merck Sharp & Dohme Therapeutic agents
EP0670320A4 (de) * 1992-12-01 1997-05-02 Green Cross Corp 1,8-naphthyridin-2-on-derivat und seine verwendung.
DE19727410A1 (de) * 1997-06-27 1999-01-07 Hoechst Schering Agrevo Gmbh 3-(5-Tetrazolylcarbonyl)-2-chinolone und diese enthaltende nutzpflanzenschützende Mittel
GB0316546D0 (en) 2003-07-15 2003-08-20 Novartis Ag Process for the manufacture of organic compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1444369A (en) * 1973-04-05 1976-07-28 Allen & Hanburys Ltd 1,8-naphthyridines
US3993656A (en) * 1974-11-19 1976-11-23 Merck & Co., Inc. 1,8-Naphthyridine compounds
US4035368A (en) * 1975-04-02 1977-07-12 Riker Laboratories, Inc. Substituted 3-(1H-tetrazol-5-yl)-quinoline compounds
US4350817A (en) * 1980-02-28 1982-09-21 American Home Products Corporation 4-Cl, Br or I-3-Carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphthyridine derivatives
NZ212209A (en) * 1984-05-29 1988-08-30 Pfizer Quinolone derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
KR900003650B1 (ko) 1990-05-28
EP0120483B1 (de) 1987-04-01
EP0120483A1 (de) 1984-10-03
ZA842065B (en) 1984-10-31
ES530877A0 (es) 1985-11-01
CA1241001A (en) 1988-08-23
NO841157L (no) 1984-09-26
DK163238B (da) 1992-02-10
DK165684D0 (da) 1984-03-23
KR840008153A (ko) 1984-12-13
JPS59176276A (ja) 1984-10-05
IE840720L (en) 1984-09-25
DK165684A (da) 1984-09-26
DK163238C (da) 1992-06-29
ATE26276T1 (de) 1987-04-15
AU562115B2 (en) 1987-05-28
JPH0452273B2 (de) 1992-08-21
IL71319A0 (en) 1984-06-29
AU2595284A (en) 1984-09-27
PT78289A (en) 1984-04-01
PT78289B (en) 1986-04-22
IL71319A (en) 1988-03-31
ES8601963A1 (es) 1985-11-01
GR81908B (de) 1984-12-12
NZ207581A (en) 1987-01-23
IE57073B1 (en) 1992-04-22
US4735948A (en) 1988-04-05

Similar Documents

Publication Publication Date Title
IT1199243B (it) Composti eterociclici,loro preparazione e loro impiego come medicamenti
IT7831028A0 (it) 13-alo-derivati e 13-deossi-derivati di composti c-076.
IT8004812A0 (it) Procedimento per la riduzione di emissione di nox.
DE3462895D1 (de) (1h-tetrazol-5-yl)-2(1h)-quinolinones
DE3577087D1 (de) Durch tertiaeres alkyl monosubstituiertes toluylendiamin und derivate.
DK165584D0 (da) (1h-tetrazol-5-yl)tetrazolo(1,5-a)quinoliner og dermed beslaegtede forbindelser
IT1206359B (it) Perfezionamenti relativi ai mezzi e procedimento per la costruzione di edifici.
NO844002L (no) Forsterket sjokkroer for eksplosiver
PH18222A (en) 3-(lh-tetrazol-5-yl)-4(3h)aminozolinones and method of use thereof
ATE35134T1 (de) Beta-naphthylalkylamine.
BR7703654A (pt) Composicao de cloreto de polivinila plastificada,retardante de fumaca
DE3568432D1 (de) Tetrazolothienopyridines
ATA751279A (de) Bauteilsatz fuer eckgelenke von drehkipp-fenstern, -tueren od. dgl.
DE3576076D1 (de) (tetrazolyl)thienopyridone.
NO985111L (no) Eksplosiv formulering
ES517874A0 (es) Procedimiento de preparacion de derivados de diaza-3,7a-cicloherta-(j,k)-fluorenos.
DE3485933T2 (de) Alkoxyiminoether-derivate von 5-acyl-2(1h)-pyridinonen.
IT8119427A0 (it) Composti eterociclici utili come agenti antiallergici.
ATE38030T1 (de) N-substituierte butyramide derivate.
LT2609B (lt) 4-acil-2,3-dihidro-1,4-benzoksazinu arba -benztiazinu gavimo budas

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee